Breaking News

You are here » Indian-Commodity  :  Commodities  :  Guar Seeds Commodity Business Higher On Great Export

13-May2011

Guar Seeds Commodity Business Higher On Great Export

Guar seeds commodities are dealing higher on minimal arrivals, lower futures and great export requirement from United states and European union together with retailers requirement. Late arrivals and records of low quality arrivals also have been helping the costs at some level.

The settlement for May supply was stock trading at Rs 3192.00, increase by 0.47% or Rs 15.00 from their past ending of Rs 3177.00. The offered interest of settlement was standing at 46180 lots.

The settlement for June supply was exchanging at Rs 3260.00, higher by 0.59% or Rs19.00 from their past ending of Rs 3241.00. The available interest regarding the settlement stood at 188180 tons on NCDEX.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......